Sung W. Rhee, Ph.D. (Principal Investigator)
Dr. Rhee has a unique interdisciplinary training in physics, molecular biology, advanced imaging and vascular pharmacology. His main goal is to understand and find new therapeutic uses for ion channels in vascular smooth muscle cells during hypertension and other cardiovascular diseases. His current interest is vasodilator complexes in cerebral arteries that may be important in protection against stroke.
Mr. Wong is a graduate of the University of Arkansas at Little Rock and has worked on diverse projects over the last four years. These projects include the use of DNA, molybdenum disulfide and nano-materials to create an aqueous antioxidant catalyst to improve fuel cell efficiency at UALR; genetic engineering to create the world’s first blue rose and a cellulose-ethanol conversion process using enzymes at the Blue Rose Institute at St. Vincent Hospital; quality assurance services for local craft brewers with Marygold Labs; and participation in studies of the reliability of epileptic patient seizure reporting and circadian rhythm in epilepsy with the Arkansas Epilepsy Program and Adamas Pharmaceuticals. He joined the Rhee Lab in August 2016 as a research technician studying cerebral blood flow, hypertension, and stroke.
Past Team Members
Christopher received his Ph.D. in 2015 and is now a FDA commissioner’s fellow working at NCTR.
Hillary left in 2015 to begin the Physicians Assistant program at UAMS.
Samantha has transitioned into Dr. Owen’s laboratory.